Literature DB >> 24224786

Hemoglobin Bohr effects: atomic origin of the histidine residue contributions.

Guishan Zheng1, Michael Schaefer, Martin Karplus.   

Abstract

The Bohr effect in hemoglobin, which refers to the dependence of the oxygen affinity on the pH, plays an important role in its cooperativity and physiological function. The dominant contribution to the Bohr effect arises from the difference in the pKa values of His residues of the unliganded (deoxy) and liganded (carbonmonoxy) structures. Using recent high resolution structures, the residue pKa values corresponding to the two structures are calculated. The method is based on determining the electrostatic interactions between residues in the protein, relative to those of the residue in solution, by use of the linearized finite difference Poisson-Boltzmann equation and Monte Carlo sampling of protonation states. Given that good agreement is obtained with the available experimental values for the contribution of His residues in HbA to the Bohr effect, the calculated results are used to determine the atomic origin of the pKa shift between deoxy and carbonmonoxy HbA. The contributions to the pKa shift calculated by means of the linear response approximation show that the salt bridge involving His146 plays an important role in the alkaline Bohr effect, as suggested by Perutz but that other interactions are significant as well. A corresponding analysis is made for the contribution of His143 to the acid Bohr effect for which there is no proposed explanation. The method used is summarized and the program by which it is implemented is described in the Appendix .

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24224786     DOI: 10.1021/bi401126z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Response to comment on 'Valid molecular dynamics simulations of human hemoglobin require a surprisingly large box size'.

Authors:  Krystel El Hage; Florent Hédin; Prashant K Gupta; Markus Meuwly; Martin Karplus
Journal:  Elife       Date:  2019-06-20       Impact factor: 8.140

Review 2.  New look at hemoglobin allostery.

Authors:  Yue Yuan; Ming F Tam; Virgil Simplaceanu; Chien Ho
Journal:  Chem Rev       Date:  2015-01-21       Impact factor: 60.622

3.  Lucina pectinata oxyhemoglobin (II-III) heterodimer pH susceptibility.

Authors:  Darya Marchany-Rivera; Clyde A Smith; Josiris D Rodriguez-Perez; Juan López-Garriga
Journal:  J Inorg Biochem       Date:  2020-03-07       Impact factor: 4.155

4.  Comment on 'Valid molecular dynamics simulations of human hemoglobin require a surprisingly large box size'.

Authors:  Vytautas Gapsys; Bert L de Groot
Journal:  Elife       Date:  2019-06-20       Impact factor: 8.140

5.  Dynamics of camel and human hemoglobin revealed by molecular simulations.

Authors:  Amanat Ali; Soja Saghar Soman; Ranjit Vijayan
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

6.  Quaternary Structure Transitions of Human Hemoglobin: An Atomic-Level View of the Functional Intermediate States.

Authors:  Nicole Balasco; Josephine Alba; Marco D'Abramo; Luigi Vitagliano
Journal:  J Chem Inf Model       Date:  2021-08-10       Impact factor: 6.162

7.  Visualizing the Bohr effect in hemoglobin: neutron structure of equine cyanomethemoglobin in the R state and comparison with human deoxyhemoglobin in the T state.

Authors:  Steven Dajnowicz; Sean Seaver; B Leif Hanson; S Zoë Fisher; Paul Langan; Andrey Y Kovalevsky; Timothy C Mueser
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-06-28       Impact factor: 7.652

8.  Valid molecular dynamics simulations of human hemoglobin require a surprisingly large box size.

Authors:  Krystel El Hage; Florent Hédin; Prashant K Gupta; Markus Meuwly; Martin Karplus
Journal:  Elife       Date:  2018-07-12       Impact factor: 8.140

9.  Mapping blood biochemistry by Raman spectroscopy at the cellular level.

Authors:  Victor V Volkov; Jonathan McMaster; Joanna Aizenberg; Carole C Perry
Journal:  Chem Sci       Date:  2021-12-01       Impact factor: 9.825

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.